Royal DSM and Lallemand conclude license agreement

In Illinois, Royal DSM and Canada-based Lallemand Inc. signed a joint agreement under which DSM grants to Lallemand a non-exclusive, royalty bearing license to DSM’s low-glycerol yeast technology patents (U.S. Patent No. 8,795,998). The license agreement is part of a settlement that was reached following a 2018 US Federal Court jury verdict in Wisconsin. The referenced technology in the agreement is for use in the fermentation of first-generation biofuels.

Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees.

Lallemand is a privately owned company specializing in the research, development, production, marketing and distribution of yeast, bacteria and other microorganisms for use in the food ingredient, human nutrition, animal nutrition, baking, wine, beer, distilled spirits, biofuels, plant care, cosmetic and pharmaceutical industries. Lallemand has approximately 4,000 employees located in more than 40 countries, on all continents.